TrxR-IN-9
TrxR-IN-9 is a thioredoxin reductase (TrxR) inhibitor with an IC50 of 0.26 μM. TrxR-IN-9 disrupts cellular redox balance. TrxR-IN-9 induces S-phase cell cycle arrest, promotes apoptosis and exhibits antiproliferative activity across cancer cells. TrxR-IN-9 exerts effects via synergistic nitric oxide (NO) and reactive oxygen species (ROS) action. TrxR-IN-9 can be used for the research of breast cancer, gastric cancer, colorectal cancer, liver cancer.
For research use only. We do not sell to patients.
- Formula: C20H21N3O9
- Molecular Weight:447.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
TrxR-IN-9 (11f) potently inhibits purified TrxR with an IC50 of 0.26 μM[1].
TrxR-IN-9 (10 μM; 48 h) selectively inhibits the proliferation of BGC823, HCT116, Hep G2, and MCF-7 cancer cells with IC50 values ranging from 0.32 to 1.5 μM, while showing minimal cytotoxicity to normal NIH-3T3 fibroblasts (IC50 > 50 μM)[1].
TrxR-IN-9 (0.1-2.0 μM; 48 h) inhibits TrxR activity in MCF-7 cells in a concentration-dependent manner with an IC50 of 0.33 μM[1].
TrxR-IN-9 (0.1-1 μM; 6 h) induces concentration-dependent intracellular ROS accumulation in MCF-7 cells[1].
TrxR-IN-9 (0.1-1 μM; 24 h) induces dose-dependent apoptosis in MCF-7 cells[1].
TrxR-IN-9 (0.1-1 μM; 36 h) induces concentration-dependent S-phase cell cycle arrest in MCF-7 cells[1].
TrxR-IN-9 (200 min) releases high levels of NO, which correlates with its anticancer cytotoxicity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7 breast cancer cells
-
Concentration:0.1, 0.5, 1 μM
-
Incubation Time:24 h
-
Result:Increased the number of cells with condensed apoptotic nuclei in a concentration-dependent manner.
Induced dose-dependent apoptotic cell death, with significantly elevated early and late apoptosis rates at higher concentrations.
-
Cell Line:MCF-7 breast cancer cells
-
Concentration:0.1, 0.5, 1 μM
-
Incubation Time:36 h
-
Result:Induced concentration-dependent S-phase arrest, with the percentage of cells in S phase increasing from 35.62% (control) to 43.20% at 1 μM, concurrent with decreases in G0/G1 and G2/M phase populations.
Chemical Information
-
Molecular Weight 447.40
-
Formula C20H21N3O9
-
SMILES
O=C(C1=CC=C(OCCCO[N+]([O-])=O)C=C1OCCCO[N+]([O-])=O)/C=C/C2=NC=CC=C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
TrxR-IN-9 Related Classifications
HY-181825 Related Classifications
Powered by Bioz